Title(s): CTSU E1505. A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (>=4cm) - IIIA Non-Small Cell Lung Cancer
Investigator(s):
Esther Rehmus, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): CTSU CALGB 30610. Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
Investigator(s):
Esther Rehmus, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): SWOG 0819. A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Investigator(s):
Esther Rehmus, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): RTOG 0937. Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)
Investigator(s):
Mitchel Fromm, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
Title(s): CTSU E5508. Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
Investigator(s):
Esther Rehmus, MD
Contact
Information:
McDowell Cancer Research at 330-344-6348
